FDA Inspection 1069227 — Long Beach Clinical Trials Services, Inc
The FDA completed an inspection of Long Beach Clinical Trials Services, Inc on Oct 5, 2018 in Long Beach, CA. The inspection was classified NAI (No Action Indicated — no objectionable conditions or practices were found during the inspection). Product area: Drugs.
Inspection Details
- Classification
- No Action Indicated (NAI)
- End Date
- Oct 5, 2018
- Fiscal Year
- 2019
- Product Type
- Drugs
- Project Area
- Bioresearch Monitoring
- Location
- Long Beach, CA (United States)
Additional Details
Clinical BA/BE